Another excerpt from the prospectus"Assuming the potential customer interest for COVID-19 Tests will result in 250,000 COVID-19 Tests being carried out, and the price of the Company’s PCR tests remains at US$75 to US$125 per test, the Company can expect revenues of approximately US$18.75 million to US$31.25 million over the next nine (9) to twelve (12) months, subject to any changes to the U.S. regulatory treatment of COVID-19 testing or the realization of a treatment, vaccine, or cure for COVID-19. "